Structures by: Evrard G.
Total: 24
C57H104O6
C57H104O6
Acta Crystallographica Section B (2000) 56, 2 317-321
a=11.6650(12)Å b=44.933(5)Å c=5.432(6)Å
α=87.034(10)° β=100.17(9)° γ=89.09(9)°
2-(2,4-Dibromophenylamino)-7-nitrobenzisoselenazol-3-one
C13H7Br2N3O3Se1
Acta Crystallographica Section E (2002) 58, 8 o828-o830
a=13.8685(10)Å b=8.6075(10)Å c=25.233(2)Å
α=90.00° β=90.00° γ=90.00°
8-Chloro-6-(3-dimethylaminopropylamino)-11H-pyrido[2,3-b][1,4]benzodiazepine
C17H20ClN5
Acta Crystallographica Section E (2002) 58, 1 o69-o71
a=9.0010(10)Å b=20.421(3)Å c=9.9350(10)Å
α=90.00° β=109.545(6)° γ=90.00°
Dimethyl 2-((1S)-1-((4S)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-methyl-2- nitropropyl) malonate
C14H23NO8
Acta Crystallographica Section C (1998) 54, 6 834-837
a=8.003(5)Å b=11.253(5)Å c=18.461(5)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
Dimethyl (3S)-3-((4S)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2- dimethylcyclopropane-1,1-dicarboxylate
C14H22O6
Acta Crystallographica Section C (1998) 54, 6 834-837
a=7.32010(10)Å b=10.7190(10)Å c=19.3900(10)Å
α=90.000(6)° β=90.000(4)° γ=90.000(5)°
Methyl (3S)-2-acetyl-3-((4S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-methyl- (phenylsulfonyl) pentanoate
C20H28O8S
Acta Crystallographica Section C (1998) 54, 6 834-837
a=10.6930(10)Å b=8.4460(10)Å c=11.9920(10)Å
α=90.00° β=101.268(5)° γ=90.00°
(1S)-phenyl-1-[(2S)-(3,5-dinitrobenzoyloxy)-propyl]-(2R)-methyl cyclopentane
C22H24N2O6
Acta Crystallographica Section C (1998) 54, 9 1353-1355
a=6.1890(10)Å b=10.6140(10)Å c=16.1600(10)Å
α=90.00° β=100.993(4)° γ=90.00°
C11H13NO4
C11H13NO4
Acta Crystallographica Section C (1994) 50, 1 97-100
a=11.546(6)Å b=9.360(2)Å c=4.922(3)Å
α=90.0° β=101.5(2)° γ=90.0°
C12H15NO4
C12H15NO4
Acta Crystallographica Section C (1994) 50, 1 97-100
a=7.295(3)Å b=25.653(5)Å c=6.321(2)Å
α=90.° β=90.° γ=90.°
(5,2'-dithien-2-yl)-2'-deoxyuridine
C17H16N2O5S2
Acta Crystallographica Section C (1997) 53, 7 892-895
a=14.580(2)Å b=18.5345(10)Å c=6.44770(10)Å
α=90.00° β=90.00° γ=90.00°
Lumiflavine
C13H14N6O8
Acta Crystallographica Section C (1995) 51, 6 1223-1227
a=14.0100(10)Å b=7.1040(10)Å c=34.086(2)Å
α=90° β=90° γ=90°
PGlu-Pro-NH~2~
C10H17N3O4
Acta Crystallographica Section C (1997) 53, 4 477-480
a=10.154(2)Å b=8.968(2)Å c=6.749(2)Å
α=90.00° β=104.00(20)° γ=90.00°
((1R,2S,4R,5S,6S)-exo-2-acetoxy-3,3,endo-6-trimethylbicyclo[3.1.0] hexan-exo-4-yl) camphanoate
C21H30O6
Acta Crystallographica Section C (1998) 54, 3 392-398
a=9.5450(10)Å b=32.428(5)Å c=6.8100(10)Å
α=90.00° β=90.00° γ=90.00°
C21H30O6
C21H30O6
Acta Crystallographica Section C (1998) 54, 3 392-398
a=14.7140(10)Å b=11.0010(10)Å c=14.736(2)Å
α=90.00° β=118.527(8)° γ=90.00°
((1R,2S,4R,5S,6R)-exo-2-acetoxy-3,3,exo-6-trimethylbicyclo[3.1.0] hexan-exo-4-yl) camphanoate
C21H30O6
Acta Crystallographica Section C (1998) 54, 3 392-398
a=12.8060(10)Å b=22.332(3)Å c=7.2582(10)Å
α=90.00° β=90.00° γ=90.00°
((1S,2S,4R,5R,6S)-exo-2-acetoxy-endo-6-(3-butenyl)-3,3,exo-6- trimethylbicyclo[3.1.0]hexan-exo-4-yl) camphanoate
C25H36O6
Acta Crystallographica Section C (1998) 54, 3 392-398
a=15.5800(10)Å b=12.8890(10)Å c=6.23600(10)Å
α=90.00° β=99.051(4)° γ=90.00°
2-phenyl-cis-4,6-dimethyl-1,3-diselenane
C12H16Se2
Acta Crystallographica Section C (1998) 54, 10 1505-1507
a=8.582(5)Å b=9.609(5)Å c=31.213(5)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
2:1 complex (N-cyclopentyl-4-phenylpyridinium bromide : 4-phenylpyridine)
2C16H18N1,2Br1,C11H9N1,H1Br1,H2O1
Acta Crystallographica Section C (1996) 52, 4 1033-1036
a=14.692(2)Å b=13.8800(10)Å c=9.7590(10)Å
α=90.00° β=90.00° γ=90.00°
(1S^*^,3S^*^)-3-methoxy-1-methyl-3-phenyl-3-(1,1,1-trimethylsilyl)-propyl 3,5-dinitrobenzoate.
C21H26N2O7Si
Acta Crystallographica Section C (1998) 54, 12 1944-1945
a=32.421(3)Å b=6.2350(10)Å c=22.6460(10)Å
α=90.00° β=91.333(7)° γ=90.00°
CAROXAZONE
C10H10N2O3
Acta Crystallographica Section C (1994) 50, 11 1774-1777
a=8.0934(10)Å b=19.998(3)Å c=11.926(2)Å
α=90.00° β=90.00° γ=90.00°
P-chlorophenylamidopentanoic acid
C12H14ClNO3
Acta Crystallographica Section C (1994) 50, 1774-1777
a=4.863(5)Å b=9.963(3)Å c=14.024(3)Å
α=69.99(2)° β=76.70(4)° γ=80.28(4)°
C12H15NO2S
C12H15NO2S
Acta Crystallographica Section C (1994) 50, 11 1749-1753
a=12.307(2)Å b=8.305Å c=12.516(2)Å
α=90.0° β=108.29(5)° γ=90.0°
Lumiflavine
C13H14N6O8
Acta Crystallographica Section C Crystal Structure Communications (1995) 51, 6 1223
a=14.0100(10)Å b=7.1040(10)Å c=34.086(2)Å
α=90° β=90° γ=90°
3-{4-[3(R)-hydroxybutoxy]phenyl}-(R)-5-methoxymethyloxazolidin-2-one
C15H21NO5
Acta Crystallographica Section C (1994) 50, 9 1490-1492
a=9.387(2)Å b=31.005(8)Å c=5.1952(10)Å
α=90° β=90° γ=90°